newsfilter
← Latest News
GlobeNewswire·

Century Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update

Preclinical pipeline re-prioritization to focus on four potentially transformative programs to advance toward clinic, led by CNTY-308 in B-cell mediated autoimmune diseases and malignancies New concentrated clinical